| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 1,600 | ₹1,34,400 |
| HNI / NII | 2 | 3,200 | ₹2,68,800 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII / HNI (Total) | — | 5,15,200 (47.49%) | — | ₹432.77 Cr |
| Retail Investors | — | 5,15,200 (47.49%) | — | ₹432.77 Cr |
| Total ** | — | 10,84,800 (100.00%) | — | ₹9,112.32 Cr |
| Market Maker * | — | 54,400 (5.01%) | — | ₹4.57 Cr |
| Metric | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Revenue | 5035.09 | 5595.67 | 3674.67 |
| PAT | 106.06 | 114.01 | 73.13 |
| EBITDA | — | — | — |
| Net Worth | 508.66 | 402.60 | 93.59 |
| Total Assets | 2133.99 | 1551.19 | 822.39 |
| Reserves | 215.09 | 380.02 | 92.59 |
| Borrowings | 1018.86 | 613.88 | 301.77 |
Incorporated in 2019, Saroja Pharma Industries India Limited is engaged in trading, exporting and supplying Specialty Chemicals & API.
The company deals in three types of product categories:
1. Chemical, 2. Pharma Intermediary and 3. Veterinary Pharma API. The company supplies products such as Liquide Bromine, which is used as an agro-intermediate, Ethyl Acetate, which is used as an API solvent, and other pharmaceuticals used for human and veterinary drugs, and some of them are API solvents.
APIs, known as bulk drugs or bulk actives, are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid or other forms of dosage, with the addition of other APIs or inactive ingredients.
The company exports products mainly in Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore etc.
Competitive Strength:
Saroja Pharma Industries India Ltd IPO · Expected 08 Sep 2023
Check on Registrar